PMC:7755033 / 84026-84206
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1490 | 24-26 | Species | denotes | WS | Tax:126910 |
1491 | 91-99 | Chemical | denotes | Losartan | |
1492 | 101-113 | Chemical | denotes | Procainamide | MESH:D011342 |
1493 | 115-125 | Chemical | denotes | Cinacalcet | MESH:D000069449 |
1494 | 127-134 | Chemical | denotes | Arbidol | MESH:C086979 |
1495 | 136-154 | Chemical | denotes | Hydroxychloroquine | MESH:D006886 |
1496 | 156-166 | Chemical | denotes | Oberadilol | |
1497 | 168-178 | Chemical | denotes | Poziotinib | MESH:C557213 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T850 | 0-180 | Sentence | denotes | Drug like properties of WS phytoconstituents versus FDA–approved standard reference drugs (Losartan, Procainamide, Cinacalcet, Arbidol, Hydroxychloroquine, Oberadilol, Poziotinib). |